Now accepting submissions

VIVA is pleased to announce that submissions are being accepted for Disruptive Technologies sessions at VIVA19. This is an opportunity for start-up companies to showcase their creative solutions for unmet clinical needs in the vascular space. Selected applicants will have the opportunity to present their innovative technology in the Purple Theater, followed by a panel discussion.

Submission Guidelines

The deadline is Monday, July 15, and all submissions must be sent to

Submissions should focus on a disruptive technology related to endovascular medicine. All products should be approved within the past year or pending approval. Selected presenters will have 7 minutes to present their product. VIVA will provide 1 complimentary full access registration to the person presenting in this session. Presenters must cover their own accommodation and travel expenses. The application process is simple: send 2-3 sentences describing your product to, and specify who will be presenting at the conference.

Notification of acceptance or rejection will be sent within two weeks of the July 15 deadline.

For additional questions, email